Qtron Investments’s West Pharmaceutical WST Stock Holding History

Qtron Investments’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$980K	Buy	2,729 +1,211	+80%	+$370K	0.13%	168
2026 Q1	$380K	Hold	1,518	–	–	0.05%	368
2025 Q4	$418K	Buy	+1,518	New	+$415K	0.05%	361
2024 Q2	–	Sell	-514	Closed	-$203K	–	501
2024 Q1	$203K	Buy	+514	New	+$190K	0.03%	467
2022 Q4	–	Sell	-936	Closed	-$230K	–	460
2022 Q3	$230K	Hold	936	–	–	0.06%	376
2022 Q2	$283K	Buy	+936	New	+$305K	0.06%	344
2021 Q1	–	Sell	-880	Closed	-$249K	–	388
2020 Q4	$249K	Sell	880 -1,181	-57%	-$331K	0.07%	291
2020 Q3	$567K	Sell	2,061 -437	-17%	-$116K	0.2%	126
2020 Q2	$567K	Sell	2,498 -1,907	-43%	-$375K	0.23%	115
2020 Q1	$671K	Buy	4,405 +2,932	+199%	+$451K	0.4%	72
2019 Q4	$221K	Hold	1,473	–	–	0.13%	204
2019 Q3	$209K	Buy	+1,473	New	+$203K	0.13%	226

Other funds holding WST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Qtron Investments's WST Position: Q2 2026 in Review

Qtron Investments increased its West Pharmaceutical (WST) stake by 80% in Q2 2026, buying an estimated $370K and bringing the position to 2,729 shares worth $980K. The position accounts for 0.13% of the portfolio, ranked #168.

Qtron Investments first reported a position in WST in Q3 2019 and has held it in 12 quarters since. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

Qtron Investments held 2,729 shares of West Pharmaceutical worth $980K as of Q2 2026.
Qtron Investments bought 1,211 West Pharmaceutical shares in Q2 2026, an estimated $370K.
West Pharmaceutical made up 0.13% of Qtron Investments's portfolio in Q2 2026, its #168 holding.
Qtron Investments first reported a position in West Pharmaceutical in Q3 2019 and has held it in 12 quarters since.
831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Qtron Investments's 13F filing for Q2 2026, filed 13 Aug 2026.